Resource Links

Status	Official Title	Lead Investigator	Last Updated
Finalised	Brand-specific influenza vaccine effectiveness in Europe, season 2019/20	Dr Margarita Riera	05/11/2020
Finalised	Brand-specific influenza vaccine effectiveness in Europe, season 2018/19	Dr Riera Marga	22/04/2020
Finalised	ADVANCE POC I Benefit-Risk pillar – testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: benefit-risk analysis of pertussis vaccines in pre-school children comparing whole-cell and acellular formulations in the post-marketing setting	Dr Kaat Bollaerts	02/09/2019
Finalised	Pilot study: reactogenicity surveillance in Belgium following immunization with seasonal influenza vaccines	Dr Antoon De Schryver	13/02/2019
Finalised	Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of pertussis and pertussis related outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children	Professor Miriam Sturkenboom	27/11/2017
Finalised	Background rates of disease in Latin American children in view of future vaccine safety assessment	Dr Thomas Verstraeten	22/06/2017
Planned	Exposure and coverage to routine schedule vaccines in different EU countries	Professor Miriam Sturkenboom	02/02/2019